September 2025
1. HSIEH HH, Tien N, Lin CL, Wong WH, et al
   Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: evidence from a population-based retrospective cohort study.
   Eur J Med Res. 2025;30:852.
   

   >> Share

   
   June 2025
2. ZHANG S, Sun T, Song L, Jin X, et al
   Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis.
   Eur J Med Res. 2025;30:509.
   

   >> Share

   
   April 2025
3. HAFIANE A, Ronca A, Incerti M, Rossi A, et al
   Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia.
   Eur J Med Res. 2025;30:266.
   

   >> Share

   
   November 2024
4. MASLUB MG, Daud NAA, Radwan MA, Sha'aban A, et al
   CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin.
   Eur J Med Res. 2024;29:539.
   

   >> Share

   
   April 2024
5. ABERA A, Worede A, Hirigo AT, Alemayehu R, et al
   Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.
   Eur J Med Res. 2024;29:237.
   

   >> Share

   
   November 2023
6. LIU Y, Ni T, Zhao Q, Cui W, et al
   Maternal hypercholesterolemia would increase the incidence of embryo aneuploidy in couples with recurrent implantation failure.
   Eur J Med Res. 2023;28:534.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share